Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.040 |
None |
1.000 |
4 |
1
|
1999 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
0.667 |
3 |
|
2010 |
2015 |
Nervous System, Organic Arsenic Poisoning
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Arsenic Encephalopathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Arsenic Induced Polyneuropathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Arsenic Poisoning
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
64
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Dermatologic disorders
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
617
|
21
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Arsenic Poisoning, Inorganic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Developmental delay (disorder)
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
584
|
68
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cutaneous Mastocytosis
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
127
|
18
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Sjogren's Syndrome
|
disease |
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
481
|
47
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Group B Streptococcal Infection
|
disease |
Infections
|
Disease or Syndrome
|
55
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
194
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Cutaneous Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
507
|
248
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anencephaly
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
59
|
10
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |